Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
Sweden · Delayed Price · Currency is SEK 0.1805
-0.0045 (-2.43%)
At close: Aug 6, 2026
XSAT:ISAB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.94 | - | 11.05 | 17.5 | 12.19 | 9.42 | |
Revenue Growth | - | - | -36.89% | 43.55% | 29.42% | -7.05% |
Cost of Revenue | 2.24 | 0.46 | 0.94 | 3.54 | 2.55 | 4.2 |
Gross Profit | 4.14 | 2.59 | 10.11 | 13.96 | 9.64 | 5.22 |
Selling, General & Admin | 9.43 | 8.61 | 8.96 | 11.08 | 13.18 | 11.88 |
Research & Development | 4.08 | 4.15 | 6.74 | 7.12 | 8.84 | 9.93 |
Other Operating Expenses | -0.05 | -0.02 | -0.52 | -0.48 | -0.35 | -0.02 |
Total Operating Expenses | 13.46 | 12.74 | 15.19 | 17.72 | 21.67 | 21.79 |
Operating Income | -9.31 | -10.16 | -5.08 | -3.76 | -12.03 | -16.57 |
Interest Income | 0.01 | 0.01 | 0.01 | 0.01 | 0 | - |
Interest Expense | -0.01 | -0.01 | -0.08 | -1 | -0.1 | -0.04 |
Total Non-Operating Income (Expense) | 0 | -0.01 | -0.07 | -0.99 | -0.1 | -0.04 |
Pretax Income | -9.31 | -10.16 | -5.15 | -4.74 | -12.13 | -16.61 |
Net Income | -9.31 | -10.16 | -5.15 | -4.74 | -12.13 | -16.61 |
Net Income to Common | -9.31 | -10.16 | -5.15 | -4.74 | -12.13 | -16.61 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 39 | 29 | 15 | 13 | 11 | 10 |
Shares Outstanding (Diluted) | 39 | 29 | 15 | 13 | 11 | 10 |
Shares Change | 158.57% | 91.72% | 14.29% | 16.67% | 12.02% | 16.82% |
EPS (Basic) | -0.28 | -0.35 | -0.34 | -0.36 | -1.07 | -1.46 |
EPS (Diluted) | -0.28 | -0.35 | -0.34 | -0.36 | -1.07 | -1.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.6 | -10.79 | -2.94 | -3.74 | -12.05 | -18.89 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.30 | -0.37 | -0.19 | -0.28 | -1.06 | -1.86 |
Gross Margin | 442.16% | - | 91.52% | 79.77% | 79.08% | 55.40% |
Operating Margin | -994.02% | - | -45.95% | -21.46% | -98.62% | -175.88% |
Profit Margin | -993.70% | - | -46.59% | -27.10% | -99.43% | -176.28% |
FCF Margin | -1238.42% | - | -26.59% | -21.38% | -98.79% | -200.52% |
EBITDA | -8.89 | -9.7 | -3.95 | -2.64 | -10.85 | -15.39 |
EBITDA Margin | -949.09% | - | -35.76% | -15.08% | -88.95% | -163.36% |
EBIT | -9.31 | -10.16 | -5.08 | -3.76 | -12.03 | -16.57 |
EBIT Margin | -994.02% | - | -45.95% | -21.46% | -98.62% | -175.88% |